SC144

SC144 is an inhibitor of STAT and Interleukins used in studies of JAK-STAT Signaling and Immune Signaling. In practice, this places the compound in experiments that measure cytokine-responsive transcriptional signaling and immune regulation and cytokine-mediated signaling and inflammatory effector responses in cancer, cell signaling, and immunology models.

By inhibiting STAT and Interleukins, SC144 can be used to examine cytokine-responsive transcriptional signaling and immune regulation and cytokine-mediated signaling and inflammatory effector responses. The signaling pathway modulator annotation adds relevance to pathway-reporter and mechanistic-phenotyping studies, together with downstream-response mapping in the same experimental setting. In cancer, cell signaling, and immunology models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving STAT and Interleukins
• Pathway perturbation studies connected to JAK-STAT Signaling and Immune Signaling
• Concentration-response inhibition and target-dependence studies
• Pathway-reporter and mechanistic-phenotyping studies

Overall, SC144 is appropriate when a defined chemical perturbant is needed to connect STAT and Interleukins with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, cell signaling, and immunology models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.